Our deep healthcare industry knowledge, extensive relationship network and substantial transaction expertise developed as senior professionals at major global investment banks allows us to address healthcare companies' strategic advisory (M&A) and financing needs with great success.
Edgemont Capital® provides a broad range of strategic business development support services, including identifying partners and structuring
agreements for approved and development-stage pharmaceutical products such as
product development collaborations, marketing, co-marketing and licensing agreements,
as well as buy and sell-side representation for product rights and service lines.
We believe that direct transaction experience is the only way to develop world-class transaction expertise. We have completed more than 70 transactions, representing over $30 billion in combined value, including mergers, acquisitions, buy-outs, private and public debt and equity financings, joint-ventures and principal investments in our careers.
We are passionate about our clients' success. We seek to partner with our clients so that we win when our clients win. Please contact us to learn more about Edgemont Capital® and how our capabilities can benefit your organization. We look forward to speaking with you.